Nagi News - Follow Us!

We are in the news!

We are in the news!

Nagi Bioscience is featured today in the online version of French Economic TV channel BFMTV. This article (in French) introduces the technology developed by our startup and its application for avoiding testing on animals for cosmetic, chemical industries and pharmas. You can read the article online here. Good reading!

We are in the news!

We are in the news!

Nagi Bioscience is featured today in the Economic Swiss newspaper Bilan. This article (in French) presents our startup and its device that avoids testing on animals for cosmetic, chemical industries and pharmas. You can read the article online here. Good reading!

Nagi Bioscience is part of the 2018 MassChallenge Accelerator Program

Nagi Bioscience is part of the 2018 MassChallenge Accelerator Program

We are glad to announce that Nagi is among the 66 high-impact startups that will join the final stage of the MassChallenge acceleration program. Our startup will benefit from world-class mentorship, programming, and resources during for improving our business case. The accelerator program will start in June and culminate on October 30th at the MassChallenge SwitzerlandRead more about Nagi Bioscience is part of the 2018 MassChallenge Accelerator Program[…]

We are in the news!

We are in the news!

Matteo and Laurent appeared respectively in two radio show broadcasted on the Swiss Radio RTS. They discuss the today’s problematic of animal testing and how the technology developed by Nagi Bioscience can bring an innovative solution to solve this issue. You can listen the live interview of Matteo and Laurent here and here (in French).

Nagi Bioscience won the PERL Biotech Award 2018

Nagi Bioscience won the PERL Biotech Award 2018

Our CEO Laurent Mouchiroud received the prestigious PERL (Prix Entreprendre Région Lausanne) Biotech Award 2018 during a ceremony held at the Theatre de Beaulieu in Lausanne. Each year, the PERL jury, made up of academic, economic and media representatives, is responsible for selecting and nominate the laureates. These laureates will benefit, before and after the prize-givingRead more about Nagi Bioscience won the PERL Biotech Award 2018[…]

Matteo was selected for Venture Leaders Life Sciences 2018

Matteo was selected for Venture Leaders Life Sciences 2018

Every year, 10 Swiss-based entrepreneurs with international high potential are selected by venturelab for the Swiss National Startup Team. The members of this team, the venture leaders, win a week entrepreneurial and business development training based in the Boston, US. In the context of the program, he is going to pitch at the Startup ChampionsRead more about Matteo was selected for Venture Leaders Life Sciences 2018[…]

Nagi Bioscience passed Venture Kick Stage I

Nagi Bioscience passed Venture Kick Stage I

Great news: Nagi Bioscience passed stage 1 of Venture Kick! On the way for stage 2 now! Venture Kick was launched in 2007 with the vision to double the number of spin-offs at Swiss universities, to accelerate the time-to-market and to raise the attractiveness of these young companies to professional investors and industry partners. Selected members fromRead more about Nagi Bioscience passed Venture Kick Stage I[…]

Nagi Bioscience listed in Bilan’s top 50 Swiss start-up companies!

Nagi Bioscience listed in Bilan’s top 50 Swiss start-up companies!

We are glad and very proud to be among the TOP50 start-up in which to invest in 2018 selected by the prestigious swiss economic newspaper Bilan. Every year, the magazine Bilan selects 50 of the most promising StartUps in Switzerland. A jury made up of innovation professionals selects Swiss nuggets, in fields as varied as fintech, biotech,Read more about Nagi Bioscience listed in Bilan’s top 50 Swiss start-up companies![…]

We are in the news!

We are in the news!

Nagi Bioscience is featured today in the Swiss newspaper Le Temps. This article (in French) discusses the current problematic of animal testing in the scientific research and highlight the solution developed by Nagi Bioscience. You can read the article online here or on the today’s paper version of the journal in the science section. Good reading!